Date | Title | Description |
04.12.2024 | Hemodialysis and Peritoneal Dialysis Market to Surpass Valuation of USD 142.97 Billion by 2031 | SkyQuest Technology | Westford, USA, Dec. 04, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the global hemodialysis and peritoneal dialysis market size will reach a value of USD 142.97 Billion by 2031, with a CAGR of 6.5% during the forecast period (2024-2031)... |
14.07.2023 | Health
Health | ‘It was a bloodbath’: Rare dialysis complication can kill, and more could be done to stop it | Brett Kelman | (TNS) KFF Health News
Nieltje Gedney was half-asleep in her West Virginia home, watching murder mysteries over the hum of a bedside hemodialysis machine, when she felt something warm and wet in her armpit.
A needle inserted i... |
06.07.2023 | "It was a bloodbath": Rare dialysis complication can kill patients in minutes — and more could be done to stop it | Nieltje Gedney was half-asleep in her West Virginia home, watching murder mysteries over the hum of a bedside hemodialysis machine, when she felt something warm and wet in her armpit.
A needle inserted into her arm had fallen loose, breakin... |
07.08.2017 | Term Sheet — Monday, Aug. 7 | STUPID AMOUNTS OF MONEY
Good morning! Three quick things:
Paid Content How can you protect what you can't see? From ExtraHop
To wildly understate things, a SoftBank deal would be complicated. SoftBank is already invested in pretty much all ... |
26.02.2015 | NxStage gains on Q4, 2014 beats, opens Boston dialysis centers | NxStage Medical (NSDQ:NXTM) shares are up today after the home hemodialysis company reported better-than-forecast results for the 4th quarter and 2014 and said it opened 2 new dialysis centers in the Boston area.
Lawrence, Mass.-based NxSta... |
18.09.2014 | Press Release: NxStage announces FDA clearance of Single Needle Technology | LAWRENCE, Mass. —
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced its single needle technology, OneSite, has received FDA clearance.
The OneSite employs a unique dual lumen needl... |
10.09.2013 | NxStage Medical urges Medicare to pony up for home hemodialysis | Home hemodialysis system maker NxStage Medical (NSDQ:NXTM) urged the Centers for Medicare & Medicaid Services to increase coverage for home hemodialysis training for patients with end-stage renal disease.
Lawrence, Mass.-based NxStage w... |
29.04.2013 | NxStage Medical taps Funari to replace Chambon as chairman | Personnel Moves | NxStage Medical (NSDQ:NXTM) named Robert Funari to replace Philippe Chambon as non-executive chairman after 15 years on the medical device company’s board of directors.
Lawrence, Mass.-based NxStage said Funari’s resume includes stints as c... |
19.11.2012 | KCI in stealthy buyout of MoMelan | Wall Street Beat | Kinetic Concepts executed an under-the-radar buyout of skin graft developer MoMelan Technologies, according to Xconomy.com, citing an anonymous investor in MoMelan.
The acquisition, to which the investor declined to assign a value, is "... |
01.03.2012 | Sales up, losses down for NxStage Medical | NxStage Medical (NSDQ:NXTM) pared its losses and added to the top lines for the 4th quarter and full year.
The Lawrence, Mass.-based home hemodialysis system maker reported losses of $4.6 million, or 8 cents per share, on sales of $57.0 mil... |
07.02.2012 | How low can you go? Creating value with cheap medical devices | Medtronic may be able to play the price disruption game, but we ask ourselves whether the small emerging med-tech company can achieve success (and funding) with a “tons cheaper” value proposition. In theory, any company starting fresh with ... |
26.07.2011 | NxStage makes it to France in its global march | Deals Roundup | NxStage Medical, Inc. (NASDAQ:NXTM) announced a five-year distribution deal for its home hemodialysis products with French renal care company Theradial today.
The contract allows Theradial to provide NxStage’s System One and PureFlow dialys... |
03.03.2011 | INC Research brings on new CFO, aims to crack CRO industry’s top 5 | Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev... |
01.12.2010 | NxStage extends distribution footprint | NxStage Medical Inc.’s (NSDQ:NXTM) Medisystems division signed a Tennessee-based medical products supplier to expand its sales reach.
NxStage, which develops home hemodialysis products, has posted rising sales and decreasing losses in recen... |
18.11.2010 | NxStage Medical reels in $66 million in stock offering | NxStage Medical Inc. (NSDQ:NXTM) grossed $66.1 million from the sale of 3.2 million shares of its common stock.
The Lawrence, Mass.-based home hemodialysis products maker sold the shares for $20.65 each, according to a filing with the feder... |
23.07.2010 | NxStage Medical trends positive again during Q2 | NxStage Medical Inc. (NSDQ:NXTM) took another leap along the path to profitability during the second quarter, posting a 20.9 percent revenues increase and shaving losses by 34 percent.
The Lawrence, Mass.-based home hemodialysis products ma... |
12.04.2010 | NxStage expands hemodialysis supply deal | NxStage Medical Inc. (NSDQ:NXTM) expanded a supply deal with Renal Advantage Inc. to include an additional 43 dialysis centers RAI acquired from National Renal Alliance.
Lawrence, Mass.-based NxStage’s relationship with RAI dates back to Ma... |
12.03.2010 | NxStage locks in $15 million credit line from Silicon Valley Bank | NxStage Medical Inc. (NSDQ:NXTM) took advantage of favorable interest rates to lock up some more working capital, possibly for future acquisitions.
The Lawrence, Mass.-based portable dialysis maker said it has secured a two-year revolving l... |
08.03.2010 | NxStage touts study results showing improved sleep, less restless legs | NxStage Medical Inc. (NSDQ:NXTM) is touting the latest interim results from a study of its home hemodialysis system showing it helps improve patient’s sleep.
The Lawrence, Mass.-based firm said the most recent data from its Freedom trial, c... |
26.02.2010 | NxStage Medical builds revenues, narrows Q4 losses | NxStage Medical Inc. saw impressive gains in its home- and critical-care businesses during the fourth quarter, helping offset a slight decline in consumables sales and leading the manufacturer of home dialysis equipment to a smaller net los... |
23.02.2010 | NxStage names new critical care VP, GM | NxStage Medical Inc. (NSDQ:NXTM) tapped a Covidien (NYSE:COV) veteran to lead its critical care division.
The Lawrence, Mass.-based home hemodialysis firm named Elise Tordella as its new vice president and general manager of critical care t... |
03.02.2010 | NxStage inks Scandinavian distribution deal with Nordic Medcomm | NxStage Medical Inc. (NSDQ:NXTM) inked a five-year deal with Nordic Medcom AB that will see the Swedish firm distribute NxStage’s System One home hemodialysis system in Scandinavia.
Lawrence, Mass.-based NxStage said the terms of the deal i... |
19.01.2010 | NxStage taps new international VP, GM | NxStage Medical Inc. (NSDQ:NXTM) tapped John Mullen to fill its newly created international general manager position.
The Lawrence, Mass.-based home dialysis products maker said Mullen will be its vice president and general manager, interna... |
17.12.2009 | NxStage pays off again for Deerfield Capital | NxStage Medical Inc. (NSDQ:NXTM) continues to reward Deerfield Capital, as the New York-based moved to lock in profits by selling a portion of its stake in the home hemodialysis company.
The open-market transactions, completed between Dec. ... |
08.12.2009 | Deerfield Management cashes in on NxStage bounce | A New York hedge fund specializing in medical device and biotech plays cashed in again on NxStage Medical Inc. (NSDQ:NXTM), selling off about 5 percent of its overall stake after a recent bounce in the company’s stock price.
Deerfield Manag... |
26.11.2007 | Inverness Investors Go Back for Seconds, Alkermes Grabs a Slice of the GSK/Reliant Pie, Kalido Restocks the (Cash) Larder, and the Rest of Thanksgiving Week’s Deals | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Even with all the roasting, basting, and digesting everybody had to do last week, Boston-area tech businesses still managed to cut a few deals:
—Biogen Idec (NASDAQ: BIIB) agr... |
- | INC Research brings on new CFO, aims to crack CRO industry’s top 5 | INC Research, a North Carolina clinical research organization, has hired its new chief financial officer from the ranks of a fellow North Carolina company as it charts a growth course to make the Raleigh firm one of the biggest players in t... |
- | How low can you go? Creating value with cheap medical devices | In the world of high tech gadgetry, consumers are spoiled by the practical implications of Moore’s Law, namely that processing power doubles in 18 months at the same cost. Today’s $500 iPhone packs the same computing punch as did all of NAS... |